Cargando…

Apgar Score and Neurodevelopmental Outcomes at Age 5 Years in Infants Born Extremely Preterm

IMPORTANCE: The Apgar score is used worldwide as an assessment tool to estimate the vitality of newborns in their first minutes of life. Its applicability to estimate neurodevelopmental outcomes in infants born extremely preterm (EPT; <28 weeks’ gestation) is not well established. OBJECTIVE: To i...

Descripción completa

Detalles Bibliográficos
Autores principales: Ehrhardt, Harald, Aubert, Adrien M., Ådén, Ulrika, Draper, Elizabeth S., Gudmundsdottir, Anna, Varendi, Heili, Weber, Tom, Zemlin, Michael, Maier, Rolf F., Zeitlin, Jennifer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483322/
https://www.ncbi.nlm.nih.gov/pubmed/37672271
http://dx.doi.org/10.1001/jamanetworkopen.2023.32413
_version_ 1785102351716057088
author Ehrhardt, Harald
Aubert, Adrien M.
Ådén, Ulrika
Draper, Elizabeth S.
Gudmundsdottir, Anna
Varendi, Heili
Weber, Tom
Zemlin, Michael
Maier, Rolf F.
Zeitlin, Jennifer
author_facet Ehrhardt, Harald
Aubert, Adrien M.
Ådén, Ulrika
Draper, Elizabeth S.
Gudmundsdottir, Anna
Varendi, Heili
Weber, Tom
Zemlin, Michael
Maier, Rolf F.
Zeitlin, Jennifer
author_sort Ehrhardt, Harald
collection PubMed
description IMPORTANCE: The Apgar score is used worldwide as an assessment tool to estimate the vitality of newborns in their first minutes of life. Its applicability to estimate neurodevelopmental outcomes in infants born extremely preterm (EPT; <28 weeks’ gestation) is not well established. OBJECTIVE: To investigate the association between the Apgar score and neurodevelopmental outcomes in infants born EPT. DESIGN, SETTING, AND PARTICIPANTS: This cohort study was conducted using data from the Effective Perinatal Intensive Care in Europe-Screening to Improve Health in Very Preterm Infants in Europe (EPICE-SHIPS) study, a population-based cohort in 19 regions of 11 European countries in 2011 to 2012. Clinical assessments of cognition and motor function at age 5 years were performed in infants born EPT and analyzed in January to July 2023. EXPOSURES: Apgar score at 5 minutes of life categorized into 4 groups (0-3, 4-6, 7-8, and 9-10 points). MAIN OUTCOMES AND MEASURES: Cognitive and motor outcomes were assessed using the Wechsler Preschool and Primary Scale of Intelligence test of IQ derived from locally normed versions by country and the Movement Assessment Battery for Children–Second Edition. Parents additionally provided information on communication and problem-solving skills using the Ages and Stages Questionnaire, third edition (ASQ-3). All outcomes were measured as continuous variables. RESULTS: From the total cohort of 4395 infants born EPT, 2522 infants were live born, 1654 infants survived to age 5 years, and 996 infants (478 females [48.0%]) followed up had at least 1 of 3 outcome measures. After adjusting for sociodemographic variables, perinatal factors, and severe neonatal morbidities, there was no association of Apgar score with IQ, even for scores of 3 or less (β = −3.3; 95% CI, −10.5 to 3.8) compared with the score 9 to 10 category. Similarly, no association was found for ASQ-3 (β = −2.1; 95% CI, −24.6 to 20.4). Congruent results for Apgar scores of 3 or less were obtained for motor function scores for all children (β = −4.0; 95% CI, −20.1 to 12.1) and excluding children with a diagnosis of cerebral palsy (β = 0.8, 95% CI −11.7 to 13.3). CONCLUSIONS AND RELEVANCE: This study found that low Apgar scores were not associated with longer-term outcomes in infants born EPT. This finding may be associated with high interobserver variability in Apgar scoring, reduced vitality signs and poorer responses to resuscitation after birth among infants born EPT, and the association of more deleterious exposures in the neonatal intensive care unit or of socioeconomic factors with greater changes in outcomes during the first 5 years of life.
format Online
Article
Text
id pubmed-10483322
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-104833222023-09-08 Apgar Score and Neurodevelopmental Outcomes at Age 5 Years in Infants Born Extremely Preterm Ehrhardt, Harald Aubert, Adrien M. Ådén, Ulrika Draper, Elizabeth S. Gudmundsdottir, Anna Varendi, Heili Weber, Tom Zemlin, Michael Maier, Rolf F. Zeitlin, Jennifer JAMA Netw Open Original Investigation IMPORTANCE: The Apgar score is used worldwide as an assessment tool to estimate the vitality of newborns in their first minutes of life. Its applicability to estimate neurodevelopmental outcomes in infants born extremely preterm (EPT; <28 weeks’ gestation) is not well established. OBJECTIVE: To investigate the association between the Apgar score and neurodevelopmental outcomes in infants born EPT. DESIGN, SETTING, AND PARTICIPANTS: This cohort study was conducted using data from the Effective Perinatal Intensive Care in Europe-Screening to Improve Health in Very Preterm Infants in Europe (EPICE-SHIPS) study, a population-based cohort in 19 regions of 11 European countries in 2011 to 2012. Clinical assessments of cognition and motor function at age 5 years were performed in infants born EPT and analyzed in January to July 2023. EXPOSURES: Apgar score at 5 minutes of life categorized into 4 groups (0-3, 4-6, 7-8, and 9-10 points). MAIN OUTCOMES AND MEASURES: Cognitive and motor outcomes were assessed using the Wechsler Preschool and Primary Scale of Intelligence test of IQ derived from locally normed versions by country and the Movement Assessment Battery for Children–Second Edition. Parents additionally provided information on communication and problem-solving skills using the Ages and Stages Questionnaire, third edition (ASQ-3). All outcomes were measured as continuous variables. RESULTS: From the total cohort of 4395 infants born EPT, 2522 infants were live born, 1654 infants survived to age 5 years, and 996 infants (478 females [48.0%]) followed up had at least 1 of 3 outcome measures. After adjusting for sociodemographic variables, perinatal factors, and severe neonatal morbidities, there was no association of Apgar score with IQ, even for scores of 3 or less (β = −3.3; 95% CI, −10.5 to 3.8) compared with the score 9 to 10 category. Similarly, no association was found for ASQ-3 (β = −2.1; 95% CI, −24.6 to 20.4). Congruent results for Apgar scores of 3 or less were obtained for motor function scores for all children (β = −4.0; 95% CI, −20.1 to 12.1) and excluding children with a diagnosis of cerebral palsy (β = 0.8, 95% CI −11.7 to 13.3). CONCLUSIONS AND RELEVANCE: This study found that low Apgar scores were not associated with longer-term outcomes in infants born EPT. This finding may be associated with high interobserver variability in Apgar scoring, reduced vitality signs and poorer responses to resuscitation after birth among infants born EPT, and the association of more deleterious exposures in the neonatal intensive care unit or of socioeconomic factors with greater changes in outcomes during the first 5 years of life. American Medical Association 2023-09-06 /pmc/articles/PMC10483322/ /pubmed/37672271 http://dx.doi.org/10.1001/jamanetworkopen.2023.32413 Text en Copyright 2023 Ehrhardt H et al. JAMA Network Open. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Original Investigation
Ehrhardt, Harald
Aubert, Adrien M.
Ådén, Ulrika
Draper, Elizabeth S.
Gudmundsdottir, Anna
Varendi, Heili
Weber, Tom
Zemlin, Michael
Maier, Rolf F.
Zeitlin, Jennifer
Apgar Score and Neurodevelopmental Outcomes at Age 5 Years in Infants Born Extremely Preterm
title Apgar Score and Neurodevelopmental Outcomes at Age 5 Years in Infants Born Extremely Preterm
title_full Apgar Score and Neurodevelopmental Outcomes at Age 5 Years in Infants Born Extremely Preterm
title_fullStr Apgar Score and Neurodevelopmental Outcomes at Age 5 Years in Infants Born Extremely Preterm
title_full_unstemmed Apgar Score and Neurodevelopmental Outcomes at Age 5 Years in Infants Born Extremely Preterm
title_short Apgar Score and Neurodevelopmental Outcomes at Age 5 Years in Infants Born Extremely Preterm
title_sort apgar score and neurodevelopmental outcomes at age 5 years in infants born extremely preterm
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483322/
https://www.ncbi.nlm.nih.gov/pubmed/37672271
http://dx.doi.org/10.1001/jamanetworkopen.2023.32413
work_keys_str_mv AT ehrhardtharald apgarscoreandneurodevelopmentaloutcomesatage5yearsininfantsbornextremelypreterm
AT aubertadrienm apgarscoreandneurodevelopmentaloutcomesatage5yearsininfantsbornextremelypreterm
AT adenulrika apgarscoreandneurodevelopmentaloutcomesatage5yearsininfantsbornextremelypreterm
AT draperelizabeths apgarscoreandneurodevelopmentaloutcomesatage5yearsininfantsbornextremelypreterm
AT gudmundsdottiranna apgarscoreandneurodevelopmentaloutcomesatage5yearsininfantsbornextremelypreterm
AT varendiheili apgarscoreandneurodevelopmentaloutcomesatage5yearsininfantsbornextremelypreterm
AT webertom apgarscoreandneurodevelopmentaloutcomesatage5yearsininfantsbornextremelypreterm
AT zemlinmichael apgarscoreandneurodevelopmentaloutcomesatage5yearsininfantsbornextremelypreterm
AT maierrolff apgarscoreandneurodevelopmentaloutcomesatage5yearsininfantsbornextremelypreterm
AT zeitlinjennifer apgarscoreandneurodevelopmentaloutcomesatage5yearsininfantsbornextremelypreterm